Niu MT - Search Results

1

Multifunctional liquid metal-based nanoparticles with glycolysis and mitochondrial metabolism inhibition for tumor photothermal therapy.

Ding XL, Liu MD, Cheng Q, Guo WH, Niu MT, Huang QX, Zeng X, Zhang XZ. Ding XL, et al. Among authors: niu mt. Biomaterials. 2022 Feb;281:121369. doi: 10.1016/j.biomaterials.2022.121369. Epub 2022 Jan 7. Biomaterials. 2022. PMID: 35026671

2

Photoelectric Bacteria Enhance the In Situ Production of Tetrodotoxin for Antitumor Therapy.

Wang XN, Niu MT, Fan JX, Chen QW, Zhang XZ. Wang XN, et al. Among authors: niu mt. Nano Lett. 2021 May 26;21(10):4270-4279. doi: 10.1021/acs.nanolett.1c00408. Epub 2021 May 6. Nano Lett. 2021. PMID: 33955768

3

Neisseria meningitidis Opca Protein/MnO₂ Hybrid Nanoparticles for Overcoming the Blood-Brain Barrier to Treat Glioblastoma.

Dong CY, Huang QX, Cheng H, Zheng DW, Hong S, Yan Y, Niu MT, Xu JG, Zhang XZ. Dong CY, et al. Among authors: niu mt. Adv Mater. 2022 Mar;34(12):e2109213. doi: 10.1002/adma.202109213. Epub 2022 Feb 7. Adv Mater. 2022. PMID: 34995395

4

Progress of engineered bacteria for tumor therapy.

Fan JX, Niu MT, Qin YT, Sun YX, Zhang XZ. Fan JX, et al. Among authors: niu mt. Adv Drug Deliv Rev. 2022 Jun;185:114296. doi: 10.1016/j.addr.2022.114296. Epub 2022 Apr 16. Adv Drug Deliv Rev. 2022. PMID: 35439571 Review.

5

Stimulation-responsive mucoadhesive probiotics for inflammatory bowel disease treatment by scavenging reactive oxygen species and regulating gut microbiota.

Huang QX, Liang JL, Yang CH, Li K, Niu MT, Fan JX, Zhang XZ. Huang QX, et al. Among authors: niu mt. Biomaterials. 2023 Oct;301:122274. doi: 10.1016/j.biomaterials.2023.122274. Epub 2023 Aug 12. Biomaterials. 2023. PMID: 37586233

6

Immunoadjuvant-Modified Rhodobacter sphaeroides Potentiate Cancer Photothermal Immunotherapy.

Niu MT, Chen QW, Chen Z, Liu X, Huang QX, Liang JL, Zhong Z, Cheng H, Zhang XZ. Niu MT, et al. Nano Lett. 2024 Jan 10;24(1):130-139. doi: 10.1021/acs.nanolett.3c03191. Epub 2023 Dec 27. Nano Lett. 2024. PMID: 38150297

7

Oral Saccharomyces cerevisiae-Guided Enzyme Prodrug Therapy Combined with Immunotherapy for the Treatment of Orthotopic Colorectal Cancer.

Qin YT, Liu X, An JX, Chen Z, Niu MT, Yan X, Li QR, Rao ZY, Zhang XZ. Qin YT, et al. Among authors: niu mt. ACS Nano. 2024 Aug 27;18(34):23497-23507. doi: 10.1021/acsnano.4c07115. Epub 2024 Aug 15. ACS Nano. 2024. PMID: 39146387

8

Polymeric nanoformulations aimed at cancer metabolism reprogramming with high specificity to inhibit tumor growth.

Xia Y, Zhang MK, Ye JJ, Niu MT, Wang ZY, Dai XY, He ZL, Feng J. Xia Y, et al. Among authors: niu mt. Biomater Sci. 2024 Sep 25;12(19):5076-5090. doi: 10.1039/d4bm00887a. Biomater Sci. 2024. PMID: 39219371

9

Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel.

Dores GM, Jason C, Niu MT, Perez-Vilar S. Dores GM, et al. Among authors: niu mt. Am J Hematol. 2021 Sep 1;96(9):1087-1100. doi: 10.1002/ajh.26246. Epub 2021 Jun 11. Am J Hematol. 2021. PMID: 34050534 Free article.

10

Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986-2019.

Wei S, Niu MT, Dores GM. Wei S, et al. Among authors: niu mt. Drugs Real World Outcomes. 2021 Jun;8(2):253-262. doi: 10.1007/s40801-021-00242-x. Epub 2021 Mar 15. Drugs Real World Outcomes. 2021. PMID: 33721285 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters